The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
Recall does not include any metabolic deficiency nutrition formulas
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
The tie-up combines Abbisko Therapeutics’ proprietary drug discovery platform with Lilly’s disease and discovery expertise
It is estimated that one-third of our country’s population has some form of these disorders
Two out of three people under the age of 40 are at risk of prediabetes
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
